This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.



Bree Martin

Vice President Development Operations
Audentes Therapeutics Inc.

Bree Martin is the Vice President, Development Operations at Audentes Therapeutics.  Audentes Therapeutics is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases. She oversees Clinical Operations, Biometrics, Clinical Supplies, and Pharmacovigilance for their gene therapy clinical programs.  Prior to Audentes, Bree consulted biotech executives and teams with a focus on organizational development, leadership, and strategy.